These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 19999328
1. Malignant peritoneal mesothelioma: contribution and limitation of imaging for its diagnosis. Marrannes J, Delvaux S, Verheezen J. JBR-BTR; 2009; 92(5):248-50. PubMed ID: 19999328 [Abstract] [Full Text] [Related]
2. Malignant pleural and peritoneal mesothelioma: incidental diagnosis and excellent treatment results. Miliauskas S, Zemaitis M, Pranys D. J Thorac Oncol; 2009 Mar; 4(3):435-6. PubMed ID: 19247093 [No Abstract] [Full Text] [Related]
3. Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum. Lee YK, Jun HJ, Nahm JH, Lim TS, Park JS, Ahn JB, Rha SY, Chung HC, Oh HE, Song JS, Yang WI, Kim HS. Jpn J Clin Oncol; 2013 Oct; 43(10):996-1003. PubMed ID: 23964112 [Abstract] [Full Text] [Related]
4. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Jänne PA, Wozniak AJ, Belani CP, Keohan ML, Ross HJ, Polikoff JA, Mintzer DM, Taylor L, Ashland J, Ye Z, Monberg MJ, Obasaju CK. Clin Lung Cancer; 2005 Jul; 7(1):40-6. PubMed ID: 16098243 [Abstract] [Full Text] [Related]
5. [A case of malignant peritoneal mesothelioma diagnosed with laparoscopic biopsy]. Yagi Y, Maeda T, Yoshimitsu Y, Sakuma H. Gan To Kagaku Ryoho; 2014 Aug; 41(8):995-7. PubMed ID: 25132032 [Abstract] [Full Text] [Related]
6. [Clinical features of patients with malignant peritoneal mesothelioma initially presenting as a local inflammation]. Song H, Zheng G, Wei S, Yang Y, Wei X. Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):312-3. PubMed ID: 24989921 [No Abstract] [Full Text] [Related]
7. Malignant peritoneal mesothelioma (MPM) who responded to rechallenge with cisplatin and pemetrexed with current literature review. Gilani SN, Gridley R, Searle G, Jegannathen A. BMJ Case Rep; 2013 Jan 03; 2013():. PubMed ID: 23291819 [Abstract] [Full Text] [Related]
8. [A difficult to treat case of malignant peritoneal mesothelioma with peritoneal metastasis]. Ojima T, Takai Y, Yamazaki K, Kamata T, Kanno M. Gan To Kagaku Ryoho; 2013 Nov 03; 40(12):2463-5. PubMed ID: 24394145 [Abstract] [Full Text] [Related]
9. [A case of malignant peritoneal mesothelioma with the epithelioid histological type, successfully treated with pemetrexed plus cisplatin]. Kobayashi M, Moriwaki T, Ochi D, Saito R, Kobayashi K, Sugaya A, Akutsu D, Hamano Y, Imanishi M, Yamamoto Y, Yamada T, Nakano N, Sugano M, Hara K, Hyodo I. Gan To Kagaku Ryoho; 2014 Mar 03; 41(3):361-4. PubMed ID: 24743284 [Abstract] [Full Text] [Related]
10. Cisplatin plus pemetrexed therapy and subsequent immune checkpoint inhibitor administration for malignant peritoneal mesothelioma without pleural lesions: Case report. Ikushima H, Sakatani T, Ohara S, Takeshima H, Horiuchi H, Morikawa T, Usui K. Medicine (Baltimore); 2020 May 29; 99(22):e19956. PubMed ID: 32481365 [Abstract] [Full Text] [Related]
11. Peritoneal mesothelioma after environmental asbestos exposure. Rosenthal R, Langer I, Dalquen P, Marti WR, Oertli D. Swiss Surg; 2003 May 29; 9(6):311-4. PubMed ID: 14725101 [Abstract] [Full Text] [Related]
12. Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience. Lainakis G, Zagouri F, Kastritis E, Sergentanis TN, Bozas G, Dimopoulos MA, Papadimitriou CA. Tumori; 2011 May 29; 97(1):25-9. PubMed ID: 21528659 [Abstract] [Full Text] [Related]
13. [A case of diffuse peritoneal malignant mesothelioma--intraabdominal administration of cisplatin is useful for diminishing ascites]. Noguchi T, Kawamura M, Kawamura T, Shimamura T, Sasaki K, Hosono T, Sato R, Murakami K. Gan To Kagaku Ryoho; 2010 Oct 29; 37(10):1975-8. PubMed ID: 20948267 [Abstract] [Full Text] [Related]
14. Pemetrexed in the treatment of malignant mesothelioma: results from an expanded access program in Germany. Reck M, Stahel RA, von Pawel J, Karthaus M, Korfee S, Serke M, Schuette WH, Eschbach C, Fink TH, Leschinger MI, Manegold C. Respir Med; 2010 Jan 29; 104(1):142-8. PubMed ID: 19818589 [Abstract] [Full Text] [Related]
15. Chemotherapy and serum hyaluronic acid levels in malignant peritoneal mesothelioma. Hotta T, Taniguchi K, Kobayashi Y, Johata K, Sahara M, Naka T, Tanimura H, Tsubota YT. Hepatogastroenterology; 2004 Jan 29; 51(58):1073-83. PubMed ID: 15239250 [Abstract] [Full Text] [Related]
16. [A Case of Malignant Peritoneal Mesothelioma Treated with Cisplatin and Pemetrexed]. Sone T, Omori S, Hayashi K, Yamato H, Ohira K, Kondo N, Takagi Y, Kato K. Gan To Kagaku Ryoho; 2018 Jun 29; 45(6):993-995. PubMed ID: 30026430 [Abstract] [Full Text] [Related]
17. [Imaging of peritoneal mesotheliomas]. Lewin M, Arrivé L, Wendum D, Monnier-Cholley L, Bouttier E, Tubiana JM. J Radiol; 1996 Sep 29; 77(9):649-56. PubMed ID: 8944121 [Abstract] [Full Text] [Related]
18. [A case of malignant pleural mesothelioma that responded to cisplatin plus pemetrexed rechallenge]. Shukuya T, Takahashi T, Nakamura Y, Yamamoto N. Gan To Kagaku Ryoho; 2010 Mar 29; 37(3):487-90. PubMed ID: 20332689 [Abstract] [Full Text] [Related]
19. [A case of malignant peritoneal mesothelioma successfully treated with systemic chemothrapy]. Igarashi K, Hayashi M, Sato M, Aiba T, Yoneyama O, Waguri N, Furukawa K, Sugimura K, Shibuya H. Nihon Shokakibyo Gakkai Zasshi; 2012 Mar 29; 109(3):451-9. PubMed ID: 22398911 [Abstract] [Full Text] [Related]
20. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma]. Wang YY, Zhang H, Bai H, Wang SH, Wu MN, An TT, Zhao J, Zhuo ML, Duan JC, Wang ZJ, Wang J. Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar 29; 36(3):162-8. PubMed ID: 23856136 [Abstract] [Full Text] [Related] Page: [Next] [New Search]